603077 Stock Overview
Provides agricultural, chemical, and new material products. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Sichuan Hebang Biotechnology Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥1.94 |
52 Week High | CN¥2.62 |
52 Week Low | CN¥1.61 |
Beta | 0.34 |
1 Month Change | -13.39% |
3 Month Change | -6.28% |
1 Year Change | -16.74% |
3 Year Change | -42.26% |
5 Year Change | 30.20% |
Change since IPO | 55.96% |
Recent News & Updates
Earnings Not Telling The Story For Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077)
Dec 18Is Sichuan Hebang Biotechnology (SHSE:603077) A Risky Investment?
Nov 19Recent updates
Earnings Not Telling The Story For Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077)
Dec 18Is Sichuan Hebang Biotechnology (SHSE:603077) A Risky Investment?
Nov 19Returns On Capital At Sichuan Hebang Biotechnology (SHSE:603077) Have Stalled
Sep 25Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) Shares Not Telling The Full Story
Aug 16Return Trends At Sichuan Hebang Biotechnology (SHSE:603077) Aren't Appealing
Jun 04Investors Holding Back On Sichuan Hebang Biotechnology Corporation Limited (SHSE:603077)
May 13Is Sichuan Hebang Biotechnology (SHSE:603077) A Risky Investment?
Mar 07Here's Why I Think Sichuan Hebang Biotechnology (SHSE:603077) Is An Interesting Stock
Apr 21Shareholder Returns
603077 | CN Chemicals | CN Market | |
---|---|---|---|
7D | -4.9% | -2.8% | -4.0% |
1Y | -16.7% | -4.8% | 6.4% |
Return vs Industry: 603077 underperformed the CN Chemicals industry which returned -4.8% over the past year.
Return vs Market: 603077 underperformed the CN Market which returned 6.4% over the past year.
Price Volatility
603077 volatility | |
---|---|
603077 Average Weekly Movement | 5.5% |
Chemicals Industry Average Movement | 7.6% |
Market Average Movement | 8.2% |
10% most volatile stocks in CN Market | 12.1% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 603077 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603077's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 7,169 | Xiaoping Zeng | www.hebang.cn |
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products.
Sichuan Hebang Biotechnology Corporation Limited Fundamentals Summary
603077 fundamental statistics | |
---|---|
Market cap | CN¥15.57b |
Earnings (TTM) | CN¥485.52m |
Revenue (TTM) | CN¥9.20b |
32.1x
P/E Ratio1.7x
P/S RatioIs 603077 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603077 income statement (TTM) | |
---|---|
Revenue | CN¥9.20b |
Cost of Revenue | CN¥8.02b |
Gross Profit | CN¥1.18b |
Other Expenses | CN¥696.34m |
Earnings | CN¥485.52m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 29, 2025
Earnings per share (EPS) | 0.06 |
Gross Margin | 12.84% |
Net Profit Margin | 5.28% |
Debt/Equity Ratio | 17.6% |
How did 603077 perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield34%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 18:39 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sichuan Hebang Biotechnology Corporation Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Wei Liu | Haitong International Research Limited |
Turong Mai | Shenwan Hongyuan Securities |